66 related articles for article (PubMed ID: 10878514)
1. In vitro activity of eight fluoroquinolones against multiresistant Stenotrophomonas maltophilia.
Sánchez-Hernández J; Manzanares MA; Gutiérrez Zufiaurre MN; Muñoz Criado S; Muñoz Bellido JL; García-Rodríguez JA
Rev Esp Quimioter; 1999 Sep; 12(3):234-6. PubMed ID: 10878514
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.
Ribera A; Jurado A; Ruiz J; Marco F; Del Valle O; Mensa J; Chaves J; Hernández G; Jiménez de Anta MT; Vila J
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):123-8. PubMed ID: 11858908
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.
Daporta MT; Muñoz Bellido JL; Guirao GY; Hernández MS; García-Rodríguez JA
Int J Antimicrob Agents; 2004 Aug; 24(2):185-7. PubMed ID: 15288320
[TBL] [Abstract][Full Text] [Related]
5. [Activity of new quinolones against clinical isolates of Corynebacterium species].
Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
[TBL] [Abstract][Full Text] [Related]
6. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia].
Tao CM; Lü XJ; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies.
Cohn ML; Waites KB
Antimicrob Agents Chemother; 2001 Jul; 45(7):2126-8. PubMed ID: 11408235
[TBL] [Abstract][Full Text] [Related]
8. Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains.
Valdezate S; Vindel A; Saéz-Nieto JA; Baquero F; Cantón R
J Antimicrob Chemother; 2005 Jul; 56(1):220-3. PubMed ID: 15928010
[TBL] [Abstract][Full Text] [Related]
9. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
[TBL] [Abstract][Full Text] [Related]
10. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
[TBL] [Abstract][Full Text] [Related]
11. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Shultz TR; Tapsall JW; White PA
Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia.
Zhang L; Li XZ; Poole K
J Antimicrob Chemother; 2001 Oct; 48(4):549-52. PubMed ID: 11581236
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance.
Lehtopolku M; Hakanen AJ; Siitonen A; Huovinen P; Kotilainen P
J Antimicrob Chemother; 2005 Dec; 56(6):1134-8. PubMed ID: 16223936
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
[No Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia.
Valdezate S; Vindel A; Baquero F; Cantón R
Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):908-11. PubMed ID: 10691206
[TBL] [Abstract][Full Text] [Related]
17. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.
Biedenbach DJ; Croco MA; Barrett TJ; Jones RN
Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):428-31. PubMed ID: 10442421
[TBL] [Abstract][Full Text] [Related]
19. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.
Nicodemo AC; Araujo MR; Ruiz AS; Gales AC
J Antimicrob Chemother; 2004 Apr; 53(4):604-8. PubMed ID: 14973153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]